Nicola Bielefeld

发表

Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.

A. Hinke, A. Tannapfel, F. Kolligs, 2020, Clinical chemistry.

The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer

M. Schuler, A. Schramm, M. Metzenmacher, 2022, Thoracic cancer.

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

D. Schadendorf, B. Schilling, R. Murali, 2014, Modern Pathology.

pHH3 Immunostaining Improves Interobserver Agreement of Mitotic Index in Thin Melanomas

D. Schadendorf, S. Pechlivanis, F. Grabellus, 2012, The American Journal of dermatopathology.

Lack of SF3B1 R625 mutations in cutaneous melanoma

D. Schadendorf, B. Schilling, A. Sucker, 2013, Diagnostic Pathology.

Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer

M. Schuler, A. Schramm, M. Metzenmacher, 2021, Translational oncology.

Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression

M. Kloor, D. Schadendorf, B. Schilling, 2014, Clinical Cancer Research.

Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer

M. Schuler, A. Roesch, M. Wiesweg, 2020, Cancers.

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

J. Utikal, D. Schadendorf, B. Schilling, 2017, Nature Communications.

Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency.

D. Schadendorf, J. Becker, A. Roesch, 2016, Cancer research.

Diffraction of compatible random substitutions in one dimension

Edmonton, M. Baake, Nicola Bielefeld, 2017, Indagationes Mathematicae.